Stocksigma LogoStocksigma Logo

Zydus Lifesciences Concludes USFDA Inspection at UK LiqMeds Facility with Four Observations

The USFDA conducted an inspection at Zydus Lifesciences' LiqMeds facility in the UK from 9th Nov'26 to 13th Nov'26

Zydus Lifesciences Concludes USFDA Inspection at UK LiqMeds Facility with Four Observations

Zydus Lifesciences Ltd 路 Press Release 路 14 Nov 2026, 4:54 pm

Zydus Lifesciences Concludes USFDA Inspection at UK LiqMeds Facility with Four Observations The USFDA conducted an inspection at Zydus Lifesciences' LiqMeds facility in the UK from 9th Nov'26 to 13th Nov'26. The regulatory audit concluded with 4 observations. The company stated that it will work closely with the USFDA to address all observations expeditiously.

Original exchange filing (PDF)

More announcements from Zydus Lifesciences Ltd

All Zydus Lifesciences Ltd announcements